Accelerate Your Path to Clinic with BioCentriq’s LEAP™ Platform
The LEAP™ platform offered by BioCentriq provides early-stage biotech companies with novel cell therapy candidates an avenue to leverage proven expertise and assets to reach patients in record time.
Sponsors who leverage LEAP™ minimize up-front investment in process development, reduce risk, accelerate timelines and lower the cost of IND-enabling studies and clinical production.
Fill out the form below and we’ll send you a link with your free download.